NCT06077799 (INFLICT) is a clinical trial in Tachycardia, Supraventricular, sponsored by Azienda Usl di Bologna.

Who is sponsoring NCT06077799?

NCT06077799 is sponsored by Azienda Usl di Bologna.

What condition does NCT06077799 study?

NCT06077799 studies Tachycardia, Supraventricular.

Is NCT06077799 still recruiting?

NCT06077799 is currently completed. Last updated 13 April 2025.

Last reviewed 2025-04-13 · How we verify

NCT06077799: INFLICT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

prehospItal maNagement oF paroxysmaL supraventrICular Tachycardia

Completed Last updated 13 April 2025

What this trial tests

trial in Tachycardia, Supraventricular in 1,234 participants. Completed in 31 October 2024.

Timeline

14 June 2023

Primary endpoint
31 January 2024

31 October 2024

Quick facts

Lead sponsor	Azienda Usl di Bologna
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,234
Start date	14 June 2023
Primary completion	31 January 2024
Estimated completion	31 October 2024
Sites	3 locations across Italy

Conditions studied

Tachycardia, Supraventricular — all drugs for Tachycardia, Supraventricular →

Sponsor

Azienda Usl di Bologna — full company profile →

Who can join

18 and older, any sex, with Tachycardia, Supraventricular. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective multicentre study on management of supraventricular tachycardia in prehospital setting.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Prehospital management of supraventricular tachycardia: a multicentre study of current practices with a subgroup propensity score-based comparison of adenosine and electrical cardioversion in unstable patients.
Gamberini L, Carinci V, Pallavicini P, Rovera M, et al · · 2025 · cited 2× · PMID 40633750 · DOI 10.1016/j.resuscitation.2025.110707

Verify or expand the search:

Other Azienda Usl di Bologna trials

Trials by the same sponsor.

NCT07492511 — Renal and Hepatic Abnormal Doppler Patterns in Trauma · recruiting
NCT06742645 — The Use of Brief Motivational Interviewing in Community Health Centers. · NA · recruiting
NCT06395558 — intErnet-based iNterventions FOR Cardiac arrEst suRvivors · NA · recruiting
NCT06471231 — Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock · Phase 4 · recruiting
NCT06750822 — Accuracy of Automatic Contusion Volume Scanning for Predicting the Incidence of Pneumonia in Patients With Thoracic Trau · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06077799 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda Usl di Bologna
Last refreshed: 13 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06077799.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing